Symbols

BIO

Bio-Rad Laboratories A·NYSE

--(--)

Signals Analysis

Bullish signal 3

Bearish signal 1

Ample Liquidity

High Gross Profit Margin

EPS Beats Expectation

Revenue Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About BIO

Bio-Rad Laboratories, Inc.

A manufacturer of products for the life science research and clinical diagnostic markets

Industry

Life Science Tools and Services

Established Date

Listing Date

10/24/2008

Exchange

New York Stock Exchange

Full-time Employees

7,450

Fiscal Year Ends

12-31

Website

www.bio-rad.com

Security Type

Common stock

Office address

1000 Alfred Nobel Drive, Hercules, California 94547

Business

Introduction

Founded in 1952, Bio-Rad Laboratories, Inc., is a Delaware corporation. The company is a multinational life sciences and clinical diagnostic company that develops, manufactures and sells a broad portfolio of instruments, systems, reagents and consumables.

Company Financials

EPS

BIO has released its 2025 Q4 earnings. EPS was reported at 2.51, versus the expected 2.71, missing expectations. The chart below visualizes how BIO has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

BIO has released its 2025 Q4 earnings report, with revenue of 693.20M, reflecting a YoY change of 3.85%, and net profit of 720.00M, showing a YoY change of 200.59%. The Sankey diagram below clearly presents BIO's revenue sources and cost distribution.